Volume 117, Issue 2 pp. 251-258
Original Article

Impacts of COVID-19 and elective surgery cancellations on platelet supply and utilization in the Canadian Province of British Columbia

Kevin E. Shopsowitz

Kevin E. Shopsowitz

Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada

Search for more papers by this author
Christina Lim

Christina Lim

BC Provincial Blood Coordinating Office, Vancouver, British Columbia, Canada

Search for more papers by this author
Andrew W. Shih

Andrew W. Shih

Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada

Department of Pathology and Laboratory Medicine, Vancouver Coastal Health Authority, Vancouver, British Columbia, Canada

Centre for Blood Research, University of British Columbia, Vancouver, British Columbia, Canada

Search for more papers by this author
Nick Fishbane

Nick Fishbane

BC Provincial Blood Coordinating Office, Vancouver, British Columbia, Canada

Search for more papers by this author
Brian R. Berry

Brian R. Berry

Department of Pathology, Vancouver Island Health Authority, Victoria, British Columbia, Canada

Search for more papers by this author
Mark Bigham

Mark Bigham

Canadian Blood Services, Vancouver, British Columbia, Canada

Search for more papers by this author
Tanya Petraszko

Tanya Petraszko

Canadian Blood Services, Vancouver, British Columbia, Canada

Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada

Search for more papers by this author
Jacqueline Trudeau

Jacqueline Trudeau

Department of Anesthesia, Pharmacology, and Therapeutics, University of British Columbia, Vancouver, British Columbia, Canada

Search for more papers by this author
Maureen Wyatt

Maureen Wyatt

Department of Pathology and Laboratory Medicine, Interior Health Authority, Kelowna, British Columbia, Canada

Search for more papers by this author
Matthew T. S. Yan

Matthew T. S. Yan

Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada

Canadian Blood Services, Vancouver, British Columbia, Canada

Department of Pathology and Laboratory Medicine, Fraser Health Authority, New Westminster, British Columbia, Canada

Search for more papers by this author
Douglas Morrison

Corresponding Author

Douglas Morrison

Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada

BC Provincial Blood Coordinating Office, Vancouver, British Columbia, Canada

Department of Pathology and Laboratory Medicine, Children's and Women's Health Centre of BC, Vancouver, British Columbia, Canada

Correspondence

Douglas Morrison, BC Children's Hospital, 4500 Oak St., Vancouver, BC V6H 3N1, Canada.

Email: [email protected]

Search for more papers by this author
First published: 26 July 2021
Citations: 4

Funding information: None

Abstract

Background and Objectives

The coronavirus disease 2019 (COVID-19) pandemic raised concerns about the vulnerability of platelet supply and the uncertain impact of the resumption of elective surgery on utilization. We report the impact of COVID-19 on platelet supply and utilization across a large, integrated healthcare system in the Canadian province of British Columbia (BC).

Materials and Methods

Historical platelet use in BC by indication was compiled for fiscal year 2010/2011–2019/2020. Platelet collections, initial daily inventory and disposition data were assessed pre-COVID-19 (1 April 2018–15 March 2020) and for two COVID-19 time periods in BC: a shutdown phase with elective surgeries halted (16 March–17 May, 2020) and a renewal phase when elective surgeries resumed (18 May–27 September 2020); comparisons were made provincially and for individual health authorities.

Results

Historically, elective surgeries accounted for 10% of platelets transfused in BC. Initial daily supplier inventory increased from baseline during both COVID-19 periods (93/90 units vs. 75 units pre-COVID-19). During the shutdown phase, platelet utilization decreased 10.4% (41 units/week; p < 0.0001), and remained significantly decreased during the ensuing renewal period. Decreased platelet utilization was attributed to fewer transfusions during the shutdown phase followed by a decreased discard/expiry rate during the renewal phase compared to pre-COVID-19 (15.2% vs. 18.9% pre-COVID-19; p < 0.0001). Differences in COVID-19 platelet utilization patterns were noted between health authorities.

Conclusion

Decreased platelet utilization was observed in BC compared to pre-COVID-19, likely due to a transient reduction in elective surgery as well as practice and policy changes triggered by pandemic concerns.

CONFLICT OF INTEREST

No conflicts of interest were identified in the preparation of this manuscript.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.